ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Resverlogix Corp

Resverlogix Corp (RVX)

0.055
0.00
( 0.00% )
更新日時: 09:00:00

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
0.055
買値
0.05
売値
0.055
出来高
1
0.00 日の範囲 0.00
0.04 52 週間の範囲 0.095
時価総額
前日終値
0.055
始値
-
時刻
1
@
0.05
最終取引時間
23:30:00
財務取引量
-
VWAP
-
平均取引量 (3 か月)
65,202
発行済株式数
272,371,000
配当利回り
-
PER
-0.81
1 株当たり利益 (EPS)
-0.06
歳入
57k
純利益
-16.74M

Resverlogix Corp について

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Calgary, Alberta, Can
設立
-
Resverlogix Corp is listed in the Biological Pds,ex Diagnstics sector of the トロント証券取引所 with ticker RVX. The last closing price for Resverlogix was $0.06. Over the last year, Resverlogix shares have traded in a share price range of $ 0.04 to $ 0.095.

Resverlogix currently has 272,371,000 shares in issue. The market capitalisation of Resverlogix is $14.98 million. Resverlogix has a price to earnings ratio (PE ratio) of -0.81.

RVX 最新ニュース

InvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditions

VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (TSX:RVX) (OTCPink:RVXCF), a world leader in epigenetics, or gene regulation, announced that apabetalone’s...

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) today announced that apabetalone’s future clinical development related to...

Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Reduction in the Risk of Major Adverse...

Resverlogix Announces Appointment of New Chief Scientific Officer

CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the appointment of Dr. Ewelina Kulikowski, Ph.D. as Chief Scientific Officer. Dr...

Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders

CALGARY, Alberta, June 21, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today held its Annual Meeting of Shareholders (the “Meeting”) in Calgary...

Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors

CALGARY, Alberta, June 08, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Breaking boundaries: Pan BETi disrupt 3D...

Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

CALGARY, Alberta, May 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix", or "the Company") (TSX:RVX), in partnership with EVERSANA™, today announced that the U.S. Food and Drug...

Resverlogix Announces One-Year Extension of Debenture

CALGARY, Alberta, April 19, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) announced today that it has closed a one-year extension of Company’s US$6.0...

Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “BET Protein Inhibition for Pulmonary...

Resverlogix Corp. to Webcast Live at VirtualInvestorConferences.com March 10th

CALGARY, Alberta, March 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX), a global leader in the development of epigenetic therapeutics, today announced that Donald...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.005100.050.0550.05127080.05047908CS
4000.0550.060.05465660.05527279CS
12-0.01-15.38461538460.0650.0650.05652020.05693807CS
260.005100.050.0950.045847380.06802906CS
52-0.01-15.38461538460.0650.0950.04569430.06524362CS
156-0.625-91.91176470590.680.750.04673400.15450096CS
260-1.125-95.33898305081.181.530.04644830.41693297CS

RVX - Frequently Asked Questions (FAQ)

What is the current Resverlogix share price?
The current share price of Resverlogix is $ 0.055
How many Resverlogix shares are in issue?
Resverlogix has 272,371,000 shares in issue
What is the market cap of Resverlogix?
The market capitalisation of Resverlogix is CAD 14.98M
What is the 1 year trading range for Resverlogix share price?
Resverlogix has traded in the range of $ 0.04 to $ 0.095 during the past year
What is the PE ratio of Resverlogix?
The price to earnings ratio of Resverlogix is -0.81
What is the cash to sales ratio of Resverlogix?
The cash to sales ratio of Resverlogix is 250
What is the reporting currency for Resverlogix?
Resverlogix reports financial results in USD
What is the latest annual turnover for Resverlogix?
The latest annual turnover of Resverlogix is USD 57k
What is the latest annual profit for Resverlogix?
The latest annual profit of Resverlogix is USD -16.74M
What is the registered address of Resverlogix?
The registered address for Resverlogix is 4820 RICHARD ROAD S.W, SUITE 300, CALGARY, ALBERTA, T3E 6L1
What is the Resverlogix website address?
The website address for Resverlogix is www.resverlogix.com
Which industry sector does Resverlogix operate in?
Resverlogix operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NUMINuminus Wellness Inc
$ 0.045
(28.57%)
612.2k
SCYScandium International Mining Corp
$ 0.025
(25.00%)
420.99k
GMTNGold Mountain Mining Corp
$ 0.025
(25.00%)
8.2k
GRCGold Springs Resource Corp
$ 0.075
(15.38%)
102.8k
WRXWestern Resources Corp
$ 0.04
(14.29%)
10k
FLNTFlint Corporation
$ 0.025
(-16.67%)
1,000
VQSVIQ Solutions Inc
$ 0.22
(-12.00%)
2k
MDAMDA Space Ltd
$ 24.15
(-10.89%)
1.7M
CEMXCematrix Corp
$ 0.22
(-10.20%)
422.04k
FTFortune Minerals Limited
$ 0.045
(-10.00%)
15.01k
DSVDiscovery Silver Corp
$ 1.41
(5.22%)
3.54M
RYRoyal Bank of Canada
$ 176.36
(-0.38%)
3.45M
BMOBank of Montreal
$ 145.16
(0.39%)
2.2M
NXENexGen Energy Ltd
$ 9.54
(4.95%)
2.03M
BTEBaytex Energy Corp
$ 3.53
(0.28%)
1.97M

最近閲覧した銘柄

Delayed Upgrade Clock